Pharmacokinetics and Safety of Velpatasvir and Sofosbuvir/Velpatasvir in Subjects with Hepatic Impairment. [electronic resource]
Producer: 20191007Description: 1449-1457 p. digitalISSN:- 1179-1926
- Adolescent
- Adult
- Aged
- Antiviral Agents -- adverse effects
- Carbamates -- adverse effects
- Drug Combinations
- Drug Therapy, Combination -- statistics & numerical data
- Female
- Hepatic Insufficiency -- blood
- Hepatitis C -- blood
- Heterocyclic Compounds, 4 or More Rings -- adverse effects
- Humans
- Liver Cirrhosis -- blood
- Male
- Middle Aged
- Ribavirin -- therapeutic use
- Sofosbuvir -- adverse effects
- Uridine -- analogs & derivatives
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.